Seer Q4 revenue rises 5% yr/yr, net loss narrows

Reuters02-27

Seer Q4 revenue rises 5% yr/yr, net loss narrows

Overview

Proteomics firm's Q4 revenue rose 5% yr/yr, driven by higher product sales
Net loss for Q4 narrowed to $16 mln from $21.7 mln yr/yr
Operating expenses for Q4 fell 23% due to reduced stock-based compensation

Outlook

Seer expects full-year 2026 revenue between $16 mln and $18 mln
Company faces ongoing budgetary pressures, including NIH funding uncertainty
Seer confident about opportunities in 2026 due to installed base growth

Result Drivers

INSTALLED BASE GROWTH - Seer expanded its installed base to 82 instruments, a 67% increase year-over-year, with 33 instruments installed in 2025
OPERATING EXPENSE REDUCTION - Operating expenses fell 23% in Q4 due to reduced stock-based compensation, laboratory expenses, and professional services

Company press release: ID:nGNX8lQgMF

Key Details

Metric	Beat/Miss	Actual	Consensus Estimate
Q4 Revenue		$4.20 mln
Q4 EPS		-$0.29
Q4 Net Income		-$15.99 mln
Q4 Gross Margin		52%
Q4 Gross Profit		$2.18 mln
Q4 Operating Expenses		$19.57 mln

Analyst Coverage

The one available analyst rating on the shares is "buy"
The average consensus recommendation for the office equipment peer group is "buy"

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2614071142?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-27 05:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2614071142","market":"nz","top_or_hot":-1,"title":"Seer Q4 revenue rises 5% yr/yr, net loss narrows","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Seer Q4 revenue rises 5% yr/yr, net loss narrows</title></head><body><p><span>Overview</span></p><ul><li><p>Proteomics firm's Q4 revenue rose 5% yr/yr, driven by higher product sales</p></li><li><p>Net loss for Q4 narrowed to $16 mln from $21.7 mln yr/yr</p></li><li><p>Operating expenses for Q4 fell 23% due to reduced stock-based compensation</p></li></ul><p><span>Outlook</span></p><ul><li><p>Seer expects full-year 2026 revenue between $16 mln and $18 mln</p></li><li><p>Company faces ongoing budgetary pressures, including NIH funding uncertainty</p></li><li><p>Seer confident about opportunities in 2026 due to installed base growth</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>INSTALLED BASE GROWTH - Seer expanded its installed base to 82 instruments, a 67% increase year-over-year, with 33 instruments installed in 2025</p></li><li><p>OPERATING EXPENSE REDUCTION - Operating expenses fell 23% in Q4 due to reduced stock-based compensation, laboratory expenses, and professional services</p></li></ul><p>Company press release: <span>ID:nGNX8lQgMF</span></p><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Q4 Revenue</p></td><td></td><td><p>$4.20 mln</p></td><td></td></tr><tr><td><p>Q4 EPS</p></td><td></td><td><p>-$0.29</p></td><td></td></tr><tr><td><p>Q4 Net Income</p></td><td></td><td><p>-$15.99 mln</p></td><td></td></tr><tr><td><p>Q4 Gross Margin</p></td><td></td><td><p>52%</p></td><td></td></tr><tr><td><p>Q4 Gross Profit</p></td><td></td><td><p>$2.18 mln</p></td><td></td></tr><tr><td><p>Q4 Operating Expenses</p></td><td></td><td><p>$19.57 mln</p></td><td></td></tr></tbody></table><p><span>Analyst Coverage</span></p><ul><li><p>The one available analyst rating on the shares is \"buy\"</p></li><li><p>The average consensus recommendation for the office equipment peer group is \"buy\"</p></li></ul><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Seer Q4 revenue rises 5% yr/yr, net loss narrows</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSeer Q4 revenue rises 5% yr/yr, net loss narrows\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-27 05:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Seer Q4 revenue rises 5% yr/yr, net loss narrows</title></head><body><p><span>Overview</span></p><ul><li><p>Proteomics firm's Q4 revenue rose 5% yr/yr, driven by higher product sales</p></li><li><p>Net loss for Q4 narrowed to $16 mln from $21.7 mln yr/yr</p></li><li><p>Operating expenses for Q4 fell 23% due to reduced stock-based compensation</p></li></ul><p><span>Outlook</span></p><ul><li><p>Seer expects full-year 2026 revenue between $16 mln and $18 mln</p></li><li><p>Company faces ongoing budgetary pressures, including NIH funding uncertainty</p></li><li><p>Seer confident about opportunities in 2026 due to installed base growth</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>INSTALLED BASE GROWTH - Seer expanded its installed base to 82 instruments, a 67% increase year-over-year, with 33 instruments installed in 2025</p></li><li><p>OPERATING EXPENSE REDUCTION - Operating expenses fell 23% in Q4 due to reduced stock-based compensation, laboratory expenses, and professional services</p></li></ul><p>Company press release: <span>ID:nGNX8lQgMF</span></p><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Q4 Revenue</p></td><td></td><td><p>$4.20 mln</p></td><td></td></tr><tr><td><p>Q4 EPS</p></td><td></td><td><p>-$0.29</p></td><td></td></tr><tr><td><p>Q4 Net Income</p></td><td></td><td><p>-$15.99 mln</p></td><td></td></tr><tr><td><p>Q4 Gross Margin</p></td><td></td><td><p>52%</p></td><td></td></tr><tr><td><p>Q4 Gross Profit</p></td><td></td><td><p>$2.18 mln</p></td><td></td></tr><tr><td><p>Q4 Operating Expenses</p></td><td></td><td><p>$19.57 mln</p></td><td></td></tr></tbody></table><p><span>Analyst Coverage</span></p><ul><li><p>The one available analyst rating on the shares is \"buy\"</p></li><li><p>The average consensus recommendation for the office equipment peer group is \"buy\"</p></li></ul><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4121","symbol_name":"生命科学工具和服务","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nL1N3ZM1GT:1","article_id":"2614071142","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2614071142","pubTimestamp":1772142203,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Seer Q4 revenue rises 5% yr/yr, net loss narrowsOverviewProteomics firm's Q4 revenue rose 5% yr/yr, driven by higher product salesNet loss for Q4 narrowed to $16 mln from $21.7 mln yr/yrOperating expe","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4121":"生命科学工具和服务","SEER":"Seer, Inc."},"translate_title":"Seer第四季度收入同比增长5%，净亏损收窄","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SEER":0.9},"content_text":"Seer Q4 revenue rises 5% yr/yr, net loss narrowsOverviewProteomics firm's Q4 revenue rose 5% yr/yr, driven by higher product salesNet loss for Q4 narrowed to $16 mln from $21.7 mln yr/yrOperating expenses for Q4 fell 23% due to reduced stock-based compensationOutlookSeer expects full-year 2026 revenue between $16 mln and $18 mlnCompany faces ongoing budgetary pressures, including NIH funding uncertaintySeer confident about opportunities in 2026 due to installed base growthResult DriversINSTALLED BASE GROWTH - Seer expanded its installed base to 82 instruments, a 67% increase year-over-year, with 33 instruments installed in 2025OPERATING EXPENSE REDUCTION - Operating expenses fell 23% in Q4 due to reduced stock-based compensation, laboratory expenses, and professional servicesCompany press release: ID:nGNX8lQgMFKey DetailsMetricBeat/MissActualConsensus EstimateQ4 Revenue$4.20 mlnQ4 EPS-$0.29Q4 Net Income-$15.99 mlnQ4 Gross Margin52%Q4 Gross Profit$2.18 mlnQ4 Operating Expenses$19.57 mlnAnalyst CoverageThe one available analyst rating on the shares is \"buy\"The average consensus recommendation for the office equipment peer group is \"buy\"For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2614071142","isCrawlerRequest":true}